Trial Details

COMPLETED
Basic Information
Clinical ID c3631
Identifier NCT01759264
Trial Title An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn's Disease
Interventions -
Participant Information
Sponsor AbbVie (prior sponsor, Abbott)
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2013-01
Primary Completion Date 2014-05
Completion Date 2014-05